Assistant Professor
Director, Adolescent and Young Adult Mood Disorders Inpatient Service
Director,University Mental Health Services
Main Office Address
Meyer 3-166A
The Johns Hopkins Hospital
600 North Wolfe St.
Baltimore, MD 21287-5371
Phone: 410-614-4948
Fax: 410-955-0152
E-mail: ekastel1@jhmi.edu
Education
1988 | B.S. | Emory University |
1993 | M.D. | University of Wisconsin School of Medicine |
1993-1994 | General Medicine and Psychiatry Internship | Johns Hopkins Bayview Medical Center |
1994-1997 | Adult Psychiatry Residency | Johns Hopkins Hospital |
1997-1999 | Child and Adolescent Psychiatry Fellowship | University of Pittsburgh School of Medicine |
Professional Interests
Mood disorders with a particular interest in adolescent and young adult health. Also interested in medical and community education. Principal investigator of an NIMH funded, multi-site study on adolescents at risk for familial Bipolar Disorder.
Selected Publications
Hess SG, Cox TS, Gonzales LC, Kastelic EA, Mink SP, Rose LE, Swartz KL. A survey of adolescents' knowledge about depression. Arch Psychiatr Nurs. 2004 Dec;18(6):228-34.
March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J; Treatment for Adolescents With Depression Study (TADS) Team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA. 2004 Aug 18;292(7):807-20.
Pediatric Psychopharmacology. 2003, Oxford: University Press. Walkup JT, Ritter-Welzant J., Kastelic EA., Joshi N., Frosch E., Antidepressants III: Other Agents, Chapter 24: 295-308.
Riddle MA, Kastelic EA, and Frosch E. Pediatric psychopharmacology. Journal of Child Psychology and Psychiatry and Allied Disciplines 2001, 42(1): 73-90.
Kastelic EA, Labellarte MJ, and Riddle MA. Selective reuptake inhibitors for children and adolescents. Current Psychiatry Reports 2000, 2: 117-121.





